FibroGen, Inc. (0IL8.L)

USD 0.34

(-1.86%)

Eps Summary of FibroGen, Inc.

  • FibroGen, Inc.'s latest annual eps in 2023 was -2.92 USD , up 7.3% from previous year.
  • FibroGen, Inc.'s latest quarterly eps in 2024 Q2 was -0.16 USD , up 51.52% from previous quarter.
  • FibroGen, Inc. reported an annual eps of -3.15 USD in 2022, down 0.0% from previous year.
  • FibroGen, Inc. reported an annual eps of -3.15 USD in 2021, down -49.29% from previous year.
  • FibroGen, Inc. reported a quarterly eps of -0.33 USD for 2024 Q1, up 42.11% from previous quarter.
  • FibroGen, Inc. reported a quarterly eps of -0.65 USD for 2023 Q3, up 27.78% from previous quarter.

Annual Eps Chart of FibroGen, Inc. (2023 - 2012)

Historical Annual Eps of FibroGen, Inc. (2023 - 2012)

Year Eps Eps Growth
2023 -2.92 USD 7.3%
2022 -3.15 USD 0.0%
2021 -3.15 USD -49.29%
2020 -2.11 USD -137.08%
2019 -0.89 USD 13.59%
2018 -1.03 USD 40.46%
2017 -1.73 USD -76.53%
2016 -0.98 USD 30.99%
2015 -1.42 USD 55.21%
2014 -3.17 USD -890.63%
2013 -0.32 USD 53.62%
2012 -0.69 USD 0.0%

Peer Eps Comparison of FibroGen, Inc.

Name Eps Eps Difference
uniQure N.V. -6.47 USD 54.869%
Abeona Therapeutics Inc. -2.53 USD -15.415%
Aclaris Therapeutics, Inc. -1.27 USD -129.921%
Agios Pharmaceuticals, Inc. -6.33 USD 53.87%
Atara Biotherapeutics, Inc. -65.18 USD 95.52%
Cara Therapeutics, Inc. -2.19 USD -33.333%
Imunon, Inc. -2.16 USD -35.185%
Dynavax Technologies Corporation -0.05 USD -5787.097%
Editas Medicine, Inc. -2.02 USD -44.554%
Iovance Biotherapeutics, Inc. -1.89 USD -54.497%
Kala Pharmaceuticals, Inc. -17.35 USD 83.17%
Neurocrine Biosciences, Inc. 2.56 USD 214.063%
Sarepta Therapeutics, Inc. -5.80 USD 49.655%
Supernus Pharmaceuticals, Inc. 0.02 USD 12216.183%
Verastem, Inc. -3.96 USD 26.263%
Zoetis Inc. 5.08 USD 157.48%
Vertex Pharmaceuticals Incorporated 14.05 USD 120.783%
Sangamo Therapeutics, Inc. -1.48 USD -97.297%
Homology Medicines, Inc. -7.41 USD 60.594%
Nektar Therapeutics -1.45 USD -101.379%
Viking Therapeutics, Inc. -0.91 USD -220.879%
Unity Biotechnology, Inc. -2.70 USD -8.148%
Perrigo Company plc -0.09 USD -3009.691%
Esperion Therapeutics, Inc. -2.03 USD -43.842%
Walgreens Boots Alliance, Inc. -10.01 USD 70.829%
Illumina, Inc. -7.35 USD 60.272%
Thermo Fisher Scientific Inc. 15.53 USD 118.802%
IQVIA Holdings Inc. 7.39 USD 139.513%
Heron Therapeutics, Inc. -0.80 USD -265.0%
Waters Corporation 10.87 USD 126.863%
Biogen Inc. 8.02 USD 136.409%
Evolus, Inc. -1.08 USD -170.37%
Adicet Bio, Inc. -3.31 USD 11.782%
bluebird bio, Inc. -1.93 USD -51.295%
Geron Corporation -0.32 USD -812.5%
Alnylam Pharmaceuticals, Inc. -3.52 USD 17.045%
Amicus Therapeutics, Inc. -0.51 USD -472.549%
Myriad Genetics, Inc. -1.39 USD -110.072%
Intellia Therapeutics, Inc. -5.42 USD 46.125%
Mettler-Toledo International Inc. 36.10 USD 108.089%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 71.678%
BioMarin Pharmaceutical Inc. 0.89 USD 428.09%
Regeneron Pharmaceuticals, Inc. 37.05 USD 107.881%
Agilent Technologies, Inc. 4.22 USD 169.194%
OPKO Health, Inc. -0.25 USD -1068.0%
Exelixis, Inc. 0.65 USD 549.231%
Corcept Therapeutics Incorporated 1.02 USD 386.275%
Anavex Life Sciences Corp. -0.60 USD -386.667%
Axsome Therapeutics, Inc. -5.27 USD 44.592%
Ionis Pharmaceuticals, Inc. -2.56 USD -14.063%
Halozyme Therapeutics, Inc. 2.13 USD 237.089%
Blueprint Medicines Corporation -8.37 USD 65.114%
Insmed Incorporated -5.34 USD 45.318%
TG Therapeutics, Inc. 0.09 USD 3369.877%
Incyte Corporation 2.67 USD 209.363%
Emergent BioSolutions Inc. -14.85 USD 80.337%